RNF207, also known as Ring Finger Protein 207, is a protein that belongs to the RING finger E3 ligase family. It plays a role in protein degradation and regulation of cellular processes. Currently, there are limited direct inhibitors known for RNF207. However, we can explore potential indirect inhibitors by considering the signaling pathways and cellular processes in which RNF207 is involved. One potential indirect inhibitor is MG-132 [Z-Leu- Leu-Leu-CHO], a proteasome inhibitor that blocks the degradation of ubiquitinated proteins. Since RNF207 is an E3 ligase involved in protein degradation, inhibiting the proteasome with MG-132 [Z-Leu- Leu-Leu-CHO] may indirectly impact the function of RNF207 by preventing the degradation of its target proteins.
Another compound to consider is MLN 4924, which inhibits the activity of NEDD8-activating enzyme (NAE). RNF207 has been reported to interact with NEDD8, a small ubiquitin-like protein, suggesting an involvement of RNF207 in neddylation-mediated protein regulation. Inhibiting NAE with MLN 4924 may indirectly affect RNF207 function by disrupting neddylation and subsequent protein modifications. Furthermore, compounds that modulate the ubiquitin-proteasome system, such as bortezomib, may act as indirect inhibitors of RNF207. Bortezomib inhibits the 26S proteasome, leading to the accumulation of ubiquitinated proteins. By interfering with the ubiquitin-proteasome system, bortezomib may indirectly impact the activity of RNF207 and its involvement in protein degradation. Other chemicals or compounds that influence protein degradation pathways or interact with components of the ubiquitin-proteasome system may also have the potential to indirectly inhibit RNF207.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that blocks the degradation of ubiquitinated proteins. May indirectly impact RNF207 function by preventing protein degradation. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
Inhibitor of NEDD8-activating enzyme (NAE), potentially disrupting neddylation-mediated protein regulation involving RNF207. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Inhibitor of the 26S proteasome, leading to the accumulation of ubiquitinated proteins. May indirectly affect RNF207 function by disrupting protein degradation. | ||||||
MLN7243 | 1450833-55-2 | sc-507338 | 5 mg | $340.00 | ||
Inhibitor of NEDD8-activating enzyme (NAE), potentially disrupting neddylation-mediated protein regulation involving RNF207. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
Proteasome inhibitor that blocks the degradation of ubiquitinated proteins. May indirectly impact RNF207 function by preventing protein degradation. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Proteasome inhibitor that blocks the degradation of ubiquitinated proteins. Potential indirect inhibitor of RNF207 by preventing protein degradation. | ||||||